This article provides an update on the current understanding of adenoid cystic carcinoma of
the head and neck, including a review of its epidemiology, clinical behavior, pathology, …

Adequate resection margins are critical to the treatment decisions and prognosis of patients
with head and neck squamous cell carcinoma (HNSCC). However, there are numerous …

Oral squamous cell carcinoma (OSCC) is a common malignancy of the head and neck region.
OSCC has a relatively low survival rate and the incidence of the disease is increasing in …

Background and purpose The Meta-Analysis of Chemotherapy in squamous cell Head and
Neck Cancer (MACH-NC) demonstrated that concomitant chemotherapy (CT) improved …

Squamous cell carcinoma of the hypopharynx represents a distinct clinical entity. Most patients
present with significant comorbidities and advanced‐stage disease. The overall survival …

Radiotherapy (RT) is used to treat approximately 80% of patients with cancer of the head
and neck. Despite enormous advances in RT planning and delivery, a significant number of …

As a consequence of the current excellent loco-regional control rates attained using the
generally accepted treatment paradigms involving intensity-modulated radiotherapy for …

Background The definitive treatment for head and neck paraganglioma (PG) is surgical excision.
Unfortunately, surgery, particularly of vagal paraganglioma (VPG; “glomus vagale”) and …

In an era of advanced diagnostics, metastasis to cervical lymph nodes from an occult
primary tumor is a rare clinical entity and accounts for approximately 3% of head and neck …

Primary mucosal melanomas (PMMs) of the head and neck are uncommon malignancies
that arise mainly in the nasal cavity and paranasal sinuses, followed by the oral cavity. The …